Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL8807283

CCCC[N+](CCCC)(CCCC)CCCC.Cc1ccc(C(C)N(O)C(N)=O)o1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 18/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL9833807 0.73 ALOX5 (0.55) ALOX5
Tetrabuthylammonium SCHEMBL9764880 0.72 NPC1 (0.44) ALOX5
SCHEMBL8806923 0.67 ALOX5 (0.73) ALOX5
Tetrabuthylammonium SCHEMBL28209653 0.64 SLC22A1 (0.67)
SCHEMBL8806895 0.64 ALOX5 (1.00) ALOX5
SCHEMBL8807571 0.64 ALOX5 (1.00) ALOX5
SCHEMBL9473684 0.63 ALOX5 (0.65) ALOX5
Tetrabuthylammonium SCHEMBL28226462 0.62 SLC22A1 (0.63)
Tetrabuthylammonium SCHEMBL28259665 0.62 SLC22A1 (0.63)
Tetrabuthylammonium SCHEMBL29113226 0.62 SLC22A1 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320628-B1 Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase ABBOTT LAB (US) 1997-01-15 EP disclosed
US-5112848-A Antiasthmatics and antiarthritic agents ABBOTT LABORATORIES (US) 1992-05-12 US disclosed
EP-0320628-A1 Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase ABBOTT LABORATORIES (US) 1989-06-21 EP disclosed